Althea Expands Prefilled Capacity

Althea Technologies, Inc. has completed the installation of a new INOVA H3-5 high-speed syringe filling line at its large scale and commercial manufacturing facility in San Diego, CA. The expanded capacity allows the company to provide drug product in prefilled syringes from early development through commercial supply. The line will be available for production of GMP batches in 1Q11.

The INOVA H3-5 syringe line operates within a Restricted Access Barrier System (RABS) and has the ability to fill under vacuum, which facilitates handling of viscous products and products that require minimal head space. According to the company, the line accommodates nested syringes from a variety of suppliers and can produce batch sizes of more than 100,000 units. The system also incorporates non-destructive, in-process weight checks designed to minimize product loss.

Rick Hancock, president of Contract Manufacturing Services at Althea, said, “We’ve been filling syringes for clinical use for over eight years, and the addition of this new line allows us to continue to meet client requirements as they progress from late stage development through commercialization.”


Click here to learn more about Althea’s services.